In practical terms, both compounds currently sit in a transitional regulatory status: no longer explicitly restricted, but not yet authorized for routine compounding either
Pharmaceutical development is accelerating, particularly in the oral small molecule classdrugs that come in pill form, can be taken daily, and work with high target specificity (big intended effects, minimal side effects)
Figure 1: Changes in gross morphological scores amongst the four experimental treatment groups
Russian preclinical literature is the main evidence base
Here is who really needs them, at what frequency, and how we approach them at CoLaz
This guide covers how each delivery method works, the core clinical differences between them, who benefits most from each option, and what to expect regarding side effects, treatment frequency, and cost